ISRCTN15765858已完成不适用
rinary excretion levels of MMX-mesalazine in healthy volunteers: a non-randomised study
Radboud University Nijmegen Medical Centre0 个研究点目标入组 25 人开始时间: 2015年2月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. > 18 years
- •2. No comorbidity
- •3. No relevant co-medication especially NSAIDs or aspirin
- •4. Not pregnant
排除标准
- •1. Pregnancy
- •2. Relevant co-morbidity
- •3. Relevant co-medication
研究者
相似试验
进行中（未招募）
1 期
The influence of the body on the fate of mesalazine in healthy volunteersEUCTR2019-003728-19-BEKU Leuven8
招募中
不适用
In-vivo Bioequivalence study of Mezasa granules with brand drugs (PENTASA Ferring Pharmaceuticals Co, Gremany)Bio equivalence test.IRCT20200105046010N40Koushan Pharmed Pharmaceutical Company24
尚未招募
不适用
The involvement of mesalazine concentration in colonic mucosa of patients with ulcerative colitis under treatment with oral mesalazinelcerative ColitisJPRN-UMIN000011455Department of Gastroenterology and Hepatology, Kyoto University Hospital50
已完成
1 期
A study of a new gastro-resistant prolonged-release mesalazine tablet formulatioChronic inflammation of the intestinal epitheliumDigestive SystemISRCTN95265400Mogon Pharmaceuticals Sagl16
招募中
Unknown
Bioequivalence study of Mesalazine 1200 mg sustained release tabletThis study is performed on healthy volunteers and drug concentration in plasma is determined..IRCT20200105046010N94Tasnim company24